Chymopapain Production Cost Reports

The report provides a detailed analysis essential for establishing a chymopapain production plant. It encompasses all critical aspects necessary for chymopapain production, including the cost of chymopapain production, chymopapain plant cost, chymopapain production costs, and the overall chymopapain production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a chymopapain production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Chymopapain is a natural enzyme obtained from the papaya plant and is mainly used for its ability to break down proteins. It was widely used in a medical procedure called chemonucleolysis, which is a non-surgical procedure for treating herniated intervertebral discs by dissolving the soft tissue in spinal discs that caused pain. It is mainly used in the treatment of certain spinal disc problems, where it helps break down damaged disc material and reduce pressure on nerves. It is also sometimes used as an alternative to surgery in minimally invasive medical procedures for relieving back pain. It is often used in laboratory and clinical research to study enzyme activity and protein breakdown. In some cases, it is also used in the preparation of diagnostic and therapeutic formulations related to orthopaedic care. However, its use has declined due to concerns over allergic reactions and the development of safer alternatives.

The primary factor that drives the market for chymopapain is its demand as a non-surgical option for spinal treatments in patients with certain types of back problems. Its application in chemonucleolysis to dissolve the herniated nucleus pulposus in lumbar intervertebral discs for relieving nerve pressure and sciatica pain also drives its demand in the pharmaceutical industry.

Its usage in patients with confirmed disc herniation via myelography who have not responded to conservative therapies like rest or physical therapy also boosts its demand in the healthcare sector. Its involvement in the biochemical research industry for studying protein structures and other medical applications also contributes to its market growth. Industrial chymopapain procurement depends on various factors, including the cost and availability of papaya-derived enzymes, regulatory approvals for medical and commercial use, and adherence to safety standards. Additionally, advancements in enzyme stabilisation, sustainable sourcing practices, production efficiency, and dependable supplier networks largely impact its procurement and market trends.

Raw Material for Chymopapain Production

According to the chymopapain production plant project report, the major raw materials for chymopapain production includes Papaya Fruits.

Production Process of Chymopapain

The extensive chymopapain production cost report consists of the following industrial production process:

1. Production from Papaya: The production process of chymopapain begins with collecting the fresh, crude latex from unripe papaya fruits. Then, it is acidified and kept at a cold temperature to allow the enzyme to separate into solution while unwanted materials settle out. The liquid portion is filtered to remove insoluble impurities, and then salt is added to first precipitate out inert proteins, followed by further salting to precipitate chymopapain. This paste is collected and kept cold, and for better stability, the pH is adjusted to a mildly acidic range. For higher purity, the enzyme is repeatedly dissolved in a salt solution, adjusted to a suitable pH, and then reprecipitated with acid or salt to obtain pure chymopapain.

Chymopapain is a proteolytic enzyme isolated from the latex of the tropical papaya plant (Carica papaya). In its purified form, the compound appears as a white to off-white lyophilised powder that is highly soluble in salt solutions and water. It is composed of a polypeptide chain of 218 amino acids in its mature form, with a molecular weight of approximately 23,000–27,000 Da (23–27 kDa). The enzyme exhibits remarkable stability at acidic pH conditions, with an optimum pH for proteolytic activity of approximately 7.2. It has a melting point in the range of 137-182 degree Celsius. The isoelectric point of chymopapain is approximately 10.0. It is sold under the brand name Chymodiactin. The compound should be stored at low temperatures, preferably around -10 degree Celsius to -20 degree Celsius, with sodium metabisulfite as a preservative to maintain proteolytic activity. It may commonly induce allergic reactions, including anaphylaxis and anaphylactoid reactions, in sensitised individuals.